STERIS plc (NYSE: STE) Stock Competitors & Peer Comparison

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, ALC has a market cap of 35.6B. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while ALC trades at $74.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas ALC's P/E ratio is 23.31. In terms of profitability, STE's ROE is +0.11%, compared to ALC's ROE of +0.03%. Regarding short-term risk, STE is similarly volatile compared to ALC. This indicates similar risk in terms of short-term price fluctuations for STE.Check ALC's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, MLAB has a market cap of 781.3M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while MLAB trades at $139.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas MLAB's P/E ratio is 14.03. In terms of profitability, STE's ROE is +0.11%, compared to MLAB's ROE of +0.04%. Regarding short-term risk, STE is less volatile compared to MLAB. This indicates lower risk in terms of short-term price fluctuations for STE.Check MLAB's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, QDEL has a market cap of 736.9M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while QDEL trades at $10.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas QDEL's P/E ratio is 8.01. In terms of profitability, STE's ROE is +0.11%, compared to QDEL's ROE of -0.20%. Regarding short-term risk, STE is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for STE.Check QDEL's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, MOBI has a market cap of 438.4M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while MOBI trades at $13.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas MOBI's P/E ratio is -4.45. In terms of profitability, STE's ROE is +0.11%, compared to MOBI's ROE of -23.36%. Regarding short-term risk, STE is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for STE.Check MOBI's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, SI has a market cap of 432.9M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while SI trades at $20.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas SI's P/E ratio is -11.96. In terms of profitability, STE's ROE is +0.11%, compared to SI's ROE of -0.26%. Regarding short-term risk, STE is less volatile compared to SI. This indicates lower risk in terms of short-term price fluctuations for STE.Check SI's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, MASS has a market cap of 405M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while MASS trades at $9.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas MASS's P/E ratio is -16.23. In terms of profitability, STE's ROE is +0.11%, compared to MASS's ROE of -0.17%. Regarding short-term risk, STE is less volatile compared to MASS. This indicates lower risk in terms of short-term price fluctuations for STE.Check MASS's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, BWAY has a market cap of 396.5M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while BWAY trades at $10.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas BWAY's P/E ratio is 25.68. In terms of profitability, STE's ROE is +0.11%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, STE is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for STE.Check BWAY's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, LAB has a market cap of 279.3M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while LAB trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas LAB's P/E ratio is -10.11. In terms of profitability, STE's ROE is +0.11%, compared to LAB's ROE of -0.08%. Regarding short-term risk, STE is less volatile compared to LAB. This indicates lower risk in terms of short-term price fluctuations for STE.Check LAB's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, ANIK has a market cap of 179.5M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while ANIK trades at $13.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas ANIK's P/E ratio is 27.35. In terms of profitability, STE's ROE is +0.11%, compared to ANIK's ROE of -0.01%. Regarding short-term risk, STE is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for STE.Check ANIK's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while EDAP trades at $4.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas EDAP's P/E ratio is -5.80. In terms of profitability, STE's ROE is +0.11%, compared to EDAP's ROE of -2.41%. Regarding short-term risk, STE is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for STE.Check EDAP's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, TRIB has a market cap of 124.7M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while TRIB trades at $6.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas TRIB's P/E ratio is -0.10. In terms of profitability, STE's ROE is +0.11%, compared to TRIB's ROE of +0.49%. Regarding short-term risk, STE is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for STE.Check TRIB's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, APYX has a market cap of 118.4M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while APYX trades at $2.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas APYX's P/E ratio is -14.05. In terms of profitability, STE's ROE is +0.11%, compared to APYX's ROE of -0.71%. Regarding short-term risk, STE is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for STE.Check APYX's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, SKIN has a market cap of 106.3M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while SKIN trades at $16.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas SKIN's P/E ratio is -74.14. In terms of profitability, STE's ROE is +0.11%, compared to SKIN's ROE of -0.32%. Regarding short-term risk, STE is less volatile compared to SKIN. This indicates lower risk in terms of short-term price fluctuations for STE.Check SKIN's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, NYXH has a market cap of 91.6M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while NYXH trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas NYXH's P/E ratio is -0.36. In terms of profitability, STE's ROE is +0.11%, compared to NYXH's ROE of -1.57%. Regarding short-term risk, STE is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for STE.Check NYXH's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, MDAI has a market cap of 41.8M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while MDAI trades at $1.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas MDAI's P/E ratio is -2.89. In terms of profitability, STE's ROE is +0.11%, compared to MDAI's ROE of +1.01%. Regarding short-term risk, STE is less volatile compared to MDAI. This indicates lower risk in terms of short-term price fluctuations for STE.Check MDAI's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, BEAT has a market cap of 22.3M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while BEAT trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas BEAT's P/E ratio is -0.78. In terms of profitability, STE's ROE is +0.11%, compared to BEAT's ROE of -4.03%. Regarding short-term risk, STE is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for STE.Check BEAT's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, ITOC has a market cap of 13.5M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while ITOC trades at $1.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas ITOC's P/E ratio is -0.47. In terms of profitability, STE's ROE is +0.11%, compared to ITOC's ROE of -0.60%. Regarding short-term risk, STE is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for STE.Check ITOC's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, DRIO has a market cap of 12.3M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while DRIO trades at $1.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas DRIO's P/E ratio is -0.22. In terms of profitability, STE's ROE is +0.11%, compared to DRIO's ROE of +0.95%. Regarding short-term risk, STE is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for STE.Check DRIO's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, MDAIW has a market cap of 12.2M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while MDAIW trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas MDAIW's P/E ratio is -1.08. In terms of profitability, STE's ROE is +0.11%, compared to MDAIW's ROE of +1.01%. Regarding short-term risk, STE is less volatile compared to MDAIW. This indicates lower risk in terms of short-term price fluctuations for STE.Check MDAIW's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, BEATW has a market cap of 6.6M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while BEATW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas BEATW's P/E ratio is -0.02. In terms of profitability, STE's ROE is +0.11%, compared to BEATW's ROE of -4.03%. Regarding short-term risk, STE is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for STE.Check BEATW's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while QTEXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, STE's ROE is +0.11%, compared to QTEXW's ROE of N/A. Regarding short-term risk, STE is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for STE.Check QTEXW's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, WOK has a market cap of 2.9M. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while WOK trades at $1.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas WOK's P/E ratio is N/A. In terms of profitability, STE's ROE is +0.11%, compared to WOK's ROE of -0.19%. Regarding short-term risk, STE is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for STE.Check WOK's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, FEED has a market cap of 951.4K. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while FEED trades at $1.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas FEED's P/E ratio is -0.15. In terms of profitability, STE's ROE is +0.11%, compared to FEED's ROE of -0.60%. Regarding short-term risk, STE is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for STE.Check FEED's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 25.7B. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, STE is priced at $264.32 on the NYSE, while TIVC trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 25.37, whereas TIVC's P/E ratio is -0.04. In terms of profitability, STE's ROE is +0.11%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, STE is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for STE.Check TIVC's competition here